Proteon Pharmaceuticals India Profile
Key Indicators
- Authorised Capital ₹ 15.50 Cr
- Paid Up Capital ₹ 14.26 Cr
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -20.21%
- Profit Growth -66.23%
- Ebitda -91.41%
- Net Worth 82.96%
- Total Assets 27.19%
About Proteon Pharmaceuticals India
Proteon Pharmaceuticals India Private Limited (PPIPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 27 December 2017 (Seven years and one month 13 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Vetphage Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 15.50 Cr and a paid-up capital of Rs 14.26 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Proteon Pharmaceuticals India Private Limited India is Prachi Toshniwal as COMPANY SECRETARY. Pradnya Wakle, Marcio Pinheiro, and Arkadiusz Wojtasik serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999MH2017FTC303373
-
Company No.
303373
-
Company Classification
Private Limited Foreign Company Incorporated In India
-
Incorporation Date
27 Dec 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Proteon Pharmaceuticals India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prachi Toshniwal
|
Company Secretary | 08-Apr-2023 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pradnya Wakle | Director | 09-May-2024 | Current |
| Marcio Pinheiro | Director | 20-Jul-2024 | Current |
| Arkadiusz Wojtasik | Director | 15-Aug-2024 | Current |
Financial Performance of Proteon Pharmaceuticals India.
Proteon Pharmaceuticals India Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 20.21% decrease. The company also saw a substantial fall in profitability, with a 66.23% decrease in profit. The company's net worth Soared by an impressive increase of 82.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Proteon Pharmaceuticals India?
In 2023, Proteon Pharmaceuticals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Proteon Pharmaceuticals India?
Proteon Pharmaceuticals India has a workforce of 14 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Proteon Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Proteon Pharmaceuticals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
